Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Patent
1992-04-29
1996-04-16
Springer, David B.
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
546165, 546153, 514311, 514312, 514313, 514314, C07D21548, A61K 3147
Patent
active
055084079
ABSTRACT:
The present invention provides novel HIV protease inhibitors, pharmaceutical formulations containing those compounds and methods of their use.
REFERENCES:
Roberts, N. A. et al, Science, 248, 358-361 (1990).
Tam, T. F. et al., Journal of Medicinal Chemistry, 35(7), 1318-1320 (3 Apr. 1992).
Young, S. G., et al., Journal of Medicinal Chemistry, 35(10), 1702-1709 (15 May 1992).
Huff, J. R., Journal of Medicinal Chemistry, 34(8), 2305-2314 (Aug. 1991).
Snieckus, Chemical Reviews, 90, 879-933 (1990).
Beak, et al., Tetrahedron, 39, 1983-1989 (1983).
Nahm and Weinreb, Tetrahedron Letters, 22, 3815-3818 (1981).
Fehrentz and Castro, Synthesis, No. 8, 676-678 (1983).
Hammond Marlys
Kaldor Stephen W.
Eli Lilly and Company
McClain Janet T.
Springer David B.
LandOfFree
Retroviral protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Retroviral protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Retroviral protease inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-326207